Michael Lam Email & Phone Number

Cambridge, Ma, Us

Cambridge, Massachusetts, Us

Oversaw Intellia Ex Vivo Portfolio of Cell Therapy Programs – Ensured cross-functional alignment, integration of novel CRISPR and base editing platform technologies, and prioritization of resources for successful program migration from immuno-oncology target ID to allogeneic TCR T and CAR T development candidates.- Lead a diverse group of 20+ scientists, ranging from immune cell engineers, translational research, flow core & assay dev specialists, and in vivo pharmacologists- Collaborate with key stakeholders in Clinical Development, Tech Ops, Regulatory, IP, etc. to bring advanced gene edited products to the clinic- Responsible for various cell therapy technology platforms leading to target discovery, validation and product deployment

Cambridge, Massachusetts, Us

- Built a Translational Immuno-oncology group to match cutting edge CRISPR cell therapies with the right patient population- Led a group of 12+ scientists to understand the immunosuppressive nature of tumor microenvironments to facilitate biomarker identification and eventually build impactful cell therapies- Establishing an external academic and CRO footprint for Intellia to expand capabilities, resources, and access unique technologies - Managing and mentoring the next generation of scientists to communicate, collaborate and lead effectively

Lexington, Ma, Us

Member of the KSQ Leadership Team- Key contributor to company buildout on strategy, hiring, resourcing, budgeting, and logistics.Responsibilities include oncology drug discovery, target validation, and externalized CRO cell biology activities- Lead biology efforts for key programs including target validation and cell biology drug discovery activities- Oversee externalized CRO cell biology activities to establish KSQ’s drug target pipeline- Assessed external global CROs for cell biology, pharmacology and drug discovery to augment internal capabilities- Manage external CRO projects for cell biology, target validation and drug discovery efforts- Key contributor to establish workflow logistics and process management to enable maximal efficiency

Lexington, Ma, Us

Member of the KSQ Leadership Team- Key contributor to company buildout on strategy, hiring, resourcing, budgeting, and logistics.Responsibilities include oncology drug discovery, target validation, in vivo pharmacology and externalized CRO activities- Lead biology efforts for key programs including target validation and cell biology drug discovery activities- Oversee externalized CRO cell biology activities to establish KSQ’s drug target pipeline- Assessed external global CROs for cell biology, pharmacology and drug discovery to augment internal capabilities- Manage external CRO projects for cell biology, target validation and pharmacology- Key contributor to establish workflow logistics and process management to enable maximal efficiencyRecruiting talent- Hired ~25% of the company including key personnel to establish In vivo pharmacology department and vivarium setup- Involved in key hiring decisions for ~90% of the scientific team across oncology, immuno- oncology, drug discovery and bioinformatics- Spearheaded talent recruitment of early personnel to establish company platform and ‘get the ball’ rollingCompany Building - Employee #3 at KSQ Therapeutics- Oversaw and coordinated the buildout of both KSQ laboratory sites- Attention to detail: Designing the KSQ website including Careers site, business cards, managing LinkedIn job postings, interfacing with Public Relations and Graphics firms- Personal focus on company culture; happy scientists are productive scientists

Rahway, New Jersey, Us

* Oncology drug discovery Program Lead- Point of contact for program scientific strategy & operations- Coordinating cell biology, bioinformatics and in vivo pharmacology efforts* Pre-clinical Discovery Lead for MK-2206 AKTi Clinical Program- Coordinating translational oncology support for biomarker discovery & patient responder ID - Pre-clinical management of MK-2206 National Cancer Institute - Cancer Therapy Evaluation Program (CTEP) and academic key opinion leader collaborations* Responsible for managing additional strategic oncology projects across Merck's internal organization & externalized CRO network- Led discovery evaluation on due diligence efforts for in-licensing opportunities- Managed dozens of external academic & CRO interactions

Rahway, New Jersey, Us

* Oncology drug discovery Program Lead- Point of contact for program scientific strategy & operations- Coordinating cell & molecular biology and animal model generation efforts* Pre-clinical Discovery Lead for MK-2206 AKTi Clinical Program- Coordinating translational oncology support for biomarker discovery & patient responder ID - Pre-clinical management of MK-2206 NCI/CTEP and academic collaborations* Responsible for managing additional strategic oncology projects across Merck's internal matrix & externalized CROs

Rahway, New Jersey, Us

* Program Team Member: Oncology Target Validation / Lead ID Group- Involved in scientific strategy & coordinating cell biology for various Merck Oncology programs

Cambridge, Massachusetts, Us

Postdoctoral Fellow in the Laboratory of Dr. David Bartel

Ph.D., Cancer Cell Biology

American Cancer Society Postdoctoral Fellow, Microrna Cancer Biology

B.A., Biology